Christopher van Horn
Psychiatry · Leawood, KSNPI 1306825229
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 638 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 638 payments — averaging $15.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$1K
- Lundbeck LLC$936
- Corium, LLC$866
- AbbVie$825
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$814
- Neurocrine Biosciences, Inc.$618
- plus $5K from 28 others
What the payments were for
- Food & beverage$9,972100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 79 | $1,405 |
| Lundbeck LLC | 65 | $936 |
| Corium, LLC | 58 | $866 |
| AbbVie(2 entities) | 60 | $825 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 65 | $814 |
| Neurocrine Biosciences, Inc. | 33 | $618 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $581 |
| Vanda Pharmaceuticals Inc. | 21 | $506 |
| Johnson & Johnson | 27 | $483 |
| Supernus Pharmaceuticals, Inc. | 20 | $387 |
| Axsome Therapeutics, Inc. | 18 | $378 |
| Teva Pharmaceuticals USA, Inc. | 15 | $227 |
| E.r. Squibb & Sons, L.L.C. | 16 | $221 |
| Neos Therapeutics, LP | 10 | $161 |
| Tris Pharma Inc | 10 | $154 |
| Acadia Pharmaceuticals Inc | 8 | $142 |
| Biogen | 6 | $120 |
| Jazz Pharmaceuticals Inc. | 7 | $113 |
| Alkermes, Inc. | 5 | $111 |
| Merck | 7 | $105 |
| Sunovion Pharmaceuticals Inc. | 25 | $101 |
| Almatica Pharma LLC | 5 | $94 |
| Ironshore Pharmaceuticals Inc. | 6 | $93 |
| Eisai Inc. | 5 | $90 |
| Bausch Health US, LLC | 5 | $85 |
| Avanir Pharmaceuticals, Inc. | 6 | $85 |
| Shire North American Group Inc | 6 | $73 |
| Alfasigma USA, Inc. | 3 | $51 |
| Arbor Pharmaceuticals, Inc. | 3 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Noven Therapeutics, LLC | 2 | $34 |
| Amgen | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Harmony Biosciences LLC | 1 | $11 |
How this compares
$9,972 in reported general payments places this provider in the 90th percentile of 259 psychiatry providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Asenapine Maleate | 13 | $7,599 |
| TrintellixVortioxetine Hydrobromide | 12 | $3,368 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $1,077 |
| Vilazodone Hcl | 11 | $699 |
| Clomipramine Hcl | 12 | $447 |
| Benztropine Mesylate | 13 | $234 |
| Clonazepam | 18 | $229 |
| Trazodone Hcl | 25 | $145 |
| Fluoxetine Hcl | 33 | $101 |
| Sertraline Hcl | 29 | $98 |
| Olanzapine | 18 | $94 |
| Temazepam | 11 | $88 |
| Lorazepam | 27 | $57 |
| Risperidone | 15 | $53 |
| Mirtazapine | 11 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $581 | $3,36812 claims |
| Almatica Pharma LLCSertraline Hcl | $94 | $9829 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 259 psychiatry providers in Kansas.
Other psychiatry in Leawood
- Kevin MaysLeawood$548K
- Sonni ElliottLeawood$22K
- Andrew SegravesLeawood$19K
- Michael EversonLeawood$19K
- Steven SegravesLeawood$13K
- Lolitta AznaurovaLeawood$11K
- Sherman ColeLeawood$8K
- Erick BrownLeawood$8K
- Wade HachinskyLeawood$7K
- Salma VelazquezLeawood$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.